newsfilter
← Latest News
Business Wire·

Axcella Therapeutics Promotes Margaret Koziel, M.D., to Chief Medical Officer

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that Margaret Koziel, M.D., has been p